Sunday, May 22, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

NEWS

Cuban cerebrovascular protective drug CIGB-845 in the works

enfermedades-cerebrovascula

Cuban cerebrovascular protective drug CIGB-845 in the works

Havana, Feb 17 (Prensa Latina) Cuba is carrying out a project with the drug called CIGB-845, which protects the area around the affected tissue after a stroke, the local press reported.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

CIGB-845 is a therapeutic alternative based on the combination of epidermal growth factor (EGF) and growth hormone-releasing peptide 6 (GHRP6) for the treatment of neurodegenerative and cerebrovascular diseases, said the doctor of Sciences Diana Garcia, leader of the Neuroprotection program of the Research Division Biomedical Sciences of the Center for Genetic Engineering and Biotechnology (CIGB).

“So far we have carried out a phase I/II clinical study (Courage), in patients with acute cerebral infarction, which has shown satisfactory results in terms of reduction of disability resulting from cerebral infarction,” Garcia specified.

“Better survival was also seen in patients treated with the combination of epidermal growth factor and growth hormone-releasing peptide 6, compared to those who received standard therapy,” Garcia pointed out.

“Although the results are promising, they must be confirmed in phase III and phase IV clinical studies, which include a greater number of people suffering from this ailment,” García commented.

pgh/llp/mem/joe

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.